Tag: King & Wood Mallesons

Chip design software vendor Empyrean has raised RMB3.55 billion (USD522.95 million) through a listing on the ChiNext of the SZSE

Why the new Futures and Derivatives Law is a boost for China towards aligning with international practice?

Han Zhen, Lin Zhijun and Kou Chunyan have joined JunHe to strengthen the firm’s restructuring and M&A, capital markets and environmental law practices

China’s largest consumer genetic testing platform Mega Genomics raised HKD215.3 million (USD27.6 million) from its IPO on the HKEX

NaaS Technology has been listed on Nasdaq through a merger with US company RISE Education Cayman in a deal that makes NaaS the third China concepts stock to go public in the US this year and the first IPO for an electric-vehicle charging-services provider

New roles of intermediaries place them under the microscope of capital market regulation

King & Wood Mallesons acted as Hong Kong counsel with Cadwalader, Wickersham & Taft providing international counsel on the city’s first 144A catastrophe bond and only its second insurance-linked securities (ILS)

China Business Law Journal reveals the law firms that have excelled in the past year    

Intellectual property specialist Gordon Gao brought colleagues Sherry Yao, Zhang Xuting and Cassidy Guo with him from Fangda Partners to join King & Wood Mallesons as partners

After months of intensive surveys, we reveal the winners of our In-house Counsel Awards 2021-22

Easing of regulations on offshore listing brings hope for an end to a long-running Sino-US dispute

Aquila Acquisition Corporation became the first special purpose acquisition company (SPAC) to list in Hong Kong

We look back at the most significant transactions and disputes of last year as we ring in the year of the tiger